Blonanserin in the treatment of delirium.

Abstract

The purpose of the present study was to provide preliminary data on the usefulness and safety of blonanserin for patients with delirium in the intensive care unit (ICU). The charts of 32 consecutive patients with delirium in the ICU were retrospectively reviewed. These patients were treated with blonanserin. A total of 96.6% had reduction in Memorial Delirium Assessment Scale score. The proportion of patients with side-effects was 24.1%. Blonanserin may be effective and safe in the treatment of delirium in the ICU.

• Authors: Koji Kato, Keigo Yamada, Mizuki Maehara, Fumiaki Akama, Keitaro Kimoto, Mai Saito, Hiroshi Yano, Atsushi Ichimura, Hideo Matsumoto
• Journal: Psychiatry and clinical neurosciences (Psychiatry Clin Neurosci) Vol. 65 Issue 4 Pg. 389-91 (Jun 2011) ISSN: 1440-1819 [Electronic] Australia
• PMID: 21569175 (Publication Type: Journal Article)
• Copyright: © 2011 The Authors. Psychiatry and Clinical Neurosciences © 2011 Japanese Society of Psychiatry and Neurology.

Chemical References

• Antipsychotic Agents
• Dopamine Antagonists
• Piperazines
• Piperidines
• Serotonin Antagonists
• blonanserin

Topics

• Adult
• Aged
• Aged, 80 and over
• Antipsychotic Agents (therapeutic use)
• Delirium (drug therapy)
• Dopamine Antagonists (therapeutic use)
• Female
• Humans
• Male
• Middle Aged
• Piperazines (therapeutic use)
• Piperidines (therapeutic use)
• Retrospective Studies
• Serotonin Antagonists (therapeutic use)
• Treatment Outcome